HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.

Abstract
The volunteer challenge model was used to study the virulence of strains of Vibrio cholerae O1 El Tor recently isolated from cases of cholera in South America. Fifteen of the 24 volunteers (62%) were of blood group O, the group most prevalent in South America and the group at increased risk of more severe cholera. Two El T or Inaba strains and 2 El Tor Ogawa strains were given to volunteers at a dose of 1-2 x 10(6) colony-forming units. All 4 strains caused diarrhoea in 67-83% of volunteers. Volunteers with blood group antigen O had an increased attack rate for diarrhoea (P = 0.015) and a marginally increased mean diarrhoeal stool volume (P = 0.08) after challenge. One-third of the volunteers with blood group O, and none of the volunteers with other blood groups, developed severe diarrhoea (> 5 L) (P = 0.01). This study established a model of South American cholera that can be used to predict field efficacy of candidate vaccines among populations with a high prevalence of blood group antigen O.
AuthorsC O Tacket, G Losonsky, J P Nataro, S S Wasserman, S J Cryz, R Edelman, M M Levine
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1995 Jan-Feb Vol. 89 Issue 1 Pg. 75-7 ISSN: 0035-9203 [Print] England
PMID7747315 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABO Blood-Group System
  • Antibodies, Bacterial
Topics
  • ABO Blood-Group System
  • Antibodies, Bacterial (immunology)
  • Antibody Formation
  • Cholera (blood)
  • Humans
  • Vibrio cholerae (immunology, pathogenicity)
  • Virulence
  • Volunteers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: